DK0428107T3 - Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer - Google Patents

Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer

Info

Publication number
DK0428107T3
DK0428107T3 DK90121634.1T DK90121634T DK0428107T3 DK 0428107 T3 DK0428107 T3 DK 0428107T3 DK 90121634 T DK90121634 T DK 90121634T DK 0428107 T3 DK0428107 T3 DK 0428107T3
Authority
DK
Denmark
Prior art keywords
ones
treatment
isoquinolyloxazol
multidrug
quinolyl
Prior art date
Application number
DK90121634.1T
Other languages
Danish (da)
English (en)
Inventor
Sai P Sunkara
Winton D Jones
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0428107T3 publication Critical patent/DK0428107T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90121634.1T 1989-11-13 1990-11-12 Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer DK0428107T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43626289A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
DK0428107T3 true DK0428107T3 (da) 1994-02-28

Family

ID=23731760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90121634.1T DK0428107T3 (da) 1989-11-13 1990-11-12 Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer

Country Status (10)

Country Link
EP (1) EP0428107B1 (fr)
JP (1) JP2927931B2 (fr)
KR (1) KR0168645B1 (fr)
AT (1) ATE100319T1 (fr)
AU (1) AU629423B2 (fr)
DE (1) DE69006188T2 (fr)
DK (1) DK0428107T3 (fr)
ES (1) ES2062267T3 (fr)
IE (1) IE63850B1 (fr)
ZA (1) ZA908936B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863977A (en) * 1993-10-12 1999-01-26 H. B. Fuller Licensing & Financing, Inc. High molecular weight S-EB-S hot melt adhesive
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Also Published As

Publication number Publication date
IE904077A1 (en) 1991-05-22
JP2927931B2 (ja) 1999-07-28
IE63850B1 (en) 1995-06-14
DE69006188D1 (de) 1994-03-03
AU6592890A (en) 1991-05-16
EP0428107A2 (fr) 1991-05-22
EP0428107A3 (en) 1991-12-11
AU629423B2 (en) 1992-10-01
ZA908936B (en) 1991-09-25
ATE100319T1 (de) 1994-02-15
KR0168645B1 (ko) 1999-01-15
EP0428107B1 (fr) 1994-01-19
JPH03170429A (ja) 1991-07-24
DE69006188T2 (de) 1994-05-26
ES2062267T3 (es) 1994-12-16
KR910009261A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
FI873280A0 (fi) Terapeutisk anvaendning av serotonin antagonister.
GR20010300006T1 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
PT754176E (pt) Novos carbamatos e ureias como modificadores da resistencia a multiplas drogas
FI883750L (fi) Transdermal plaoster foer administrering av ett laekemedel.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
FI870415L (fi) Terapeutiskt anvaendbara /2,2-bis(aminometyl)-1,3-propandiol-n,n')-platinakomplex och deras framstaellning.
NO912558D0 (no) Mucoadhesiv baerer for avlevering av terapeutiske midler.
DK174289D0 (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion
FI911788A0 (fi) Konjugater av difluorglutaminsyra med folater och antifolater foer behandling av neoplastiska sjukdomar.
DE3765808D1 (de) Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE100319T1 (de) Verwendung von chinolyl-und isochinolyloxazol-2- onen zur herstellung eines arzneinmittels zur behandlung von gegen eine vielzahl von arzneimitteln resistenten tumoren.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8419960A0 (it) Nuove resine solfoniche adattivita' terapeutica, loro preparazione e composizioni farmaceutiche che le contengono.
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ATA67688A (de) Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren
FR2646161B1 (fr) Nouvelles lipopolyamines, leur preparation et leur emploi